01 3Epclusa
02 6Harvoni
03 2Sovaldi
04 2Sovaldi
05 2Vosevi
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 272
2019 Revenue in Millions : 643
Growth (%) : -58
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 1,462
2020 Revenue in Millions : 1,599
Growth (%) : -9
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 212
2020 Revenue in Millions : 272
Growth (%) : -22
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 1,570
2021 Revenue in Millions : 1,462
Growth (%) : 7
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 114
2021 Revenue in Millions : 212
Growth (%) : -46
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 70
2022 Revenue in Millions : 115
Growth (%) : -39
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 1,537
2022 Revenue in Millions : 1,530
Growth (%) : 0
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2015 Revenue in Millions : 10,283
2014 Revenue in Millions : 5,276
Growth (%) : -49%
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2016 Revenue in Millions : 4,001
2015 Revenue in Millions : 5,276
Growth (%) : -24
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2017 Revenue in Millions : 964
2016 Revenue in Millions : 4,001
Growth (%) : -76
LOOKING FOR A SUPPLIER?